Inside informationEnglish
AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 24/07/2025, 07:56
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 119469_20250724